col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


85 Results       Page 1

 [1] 
Elsevier: Microbes and Infection
  original article Date Title Authors   All Authors
1 [GO] 2024―Jun―22 The PDZ Domain of the E Protein in SARS-CoV Induces Carcinogenesis and Poor Prognosis in LUAD Shun Li, Jinxuan Wang, Xiaozhen Dai, Churong Li, Tao Li, Long Chen
2 [GO] 2024―May―15 Multicentric investigations of the role in the disease severity of accelerated phospholipid changes in COVID-19 patient airway. Christie Mitri, François Philippart, Emmanuelle Sacco, Stéphane Legriel, Nathalie Rousselet, Gabrielle Dupuis, et al. (+4)
3 [GO] 2024―May―07 SARS-CoV-2 prevalence in wildlife 2020-2022: a worldwide systematic review and meta-analysis Xue-Yao Yang, Jing-Shu Huang, Qing-Long Gong, Jin-Mei Sun, Yan-Jin Li, Bing Liu, et al. (+5)
4 [GO] 2024―Apr―24 A murine model of DC-SIGN humanization exhibits increased susceptibility against SARS-CoV-2 Yeqing Tu, Yitai Fang, Rui Zheng, Dan Lu, Xiaolan Yang, Liangyan Zhang, et al. (+5)
5 [GO] 2023―Nov―18 Middle East respiratory coronavirus (MERS-CoV) internalized by llama alveolar macrophages does not result in virus replication or induction of pro-inflammatory cytokines Jordi Rodon, Martin Sachse, Nigeer Te, Joaquim Segalés, Albert Bensaid, Cristina Risco, Júlia Vergara-Alert
6 [GO] 2023―Nov―08 Associations between host microbiome and inflammation suggest role for host microbiome in driving COVID-19 disease severity Rachel MacCann, Tarini Shankar Ghosh, Alejandro Abner Garcia Leon, Junhui Li, Riya Negi, Colette Gaillard, et al. (+11)
7 [GO] 2023―Oct―10 Intense P.1 (Gamma) diversification followed by rapid Delta substitution in Southern Brazil: a SARS-CoV-2 Genomic Epidemiology study Patrícia Aline Gröhs Ferrareze, Gabriela Betella Cybis, Luiz Felipe Valter de Oliveira, Ricardo Ariel Zimerman, Dieine Estela Bernieri Schiavon, Camila Peter, Claudia Elizabeth Thompson
8 [GO] 2023―Sep―20 Clinical impact of human parainfluenza virus infections before and during the COVID-19 pandemic in Southern China Ya Li, Ying Liang, Jiaqi Tang, Ning Li, Yihao Yang, Wenyu Guo, et al. (+4)
9 [GO] 2023―Sep―20 Identification of SARS-CoV-2 m6A modification sites correlate with viral pathogenicity Ke Liu, Ying-Zi Zhang, Hui Yin, Lu-Lu Yu, Jia-Jia Cui, Ji-Ye Yin, et al. (+2)
10 [GO] 2023―Jul―29 Uncovering the Morphological Differences Between SARS-CoV-2 and SARS-CoV Based on Transmission Electron Microscopy Images Bakr Ahmed Taha, Yousif Al Mashhadany, Qussay Al-Jubouri, Adawiya J. Haider, Vishal Chaudhary, Retna Apsari, Norhana Arsad
11 [GO] 2023―Jul―25 Adverse effect of VEGFR-2 (rs1870377) polymorphism on the clinical course of COVID-19 in females and males in an age-dependent manner Derya Beyza SAYIN KOCAKAP, Sedat KAYGUSUZ, Emel AKSOY, Ömer ŞAHİN, Ayşe BAÇÇIOĞLU, Aydanur EKİCİ, et al. (+8)
12 [GO] 2023―Jul―01 COVID-19 patients with high TNF/IFN-γ levels show hallmarks of PANoptosis, an inflammatory cell death Yadira Palacios, Lucero A. Ramón-Luing, Andy Ruiz, Alicia García-Martínez, Anahí Sánchez-Monciváis, Omar Barreto-Rodríguez, et al. (+5)
13 [GO] 2023―Jun―12 A systematical association analysis of 25 common virus infection and genetic susceptibility of COVID-19 infection Na Zhang, Yujing Chen, Chun'e Li, Xiaoyue Qin, Dan He, Wenming Wei, et al. (+7)
14 [GO] 2023―May―02 The mechanism of immune dysregulation caused by porcine reproductive and respiratory syndrome virus (PRRSV) Marek Sinkora, Miroslav Toman, Katerina Stepanova, Hana Stepanova, Lenka Leva, Jana Sinkorova, et al. (+14)
15 [GO] 2023―Apr―19 Mice Humanized for MHC and hACE2 with High Permissiveness to SARS-CoV-2 Omicron Replication Fabien Le Chevalier, Pierre Authié, Sébastien Chardenoux, Maryline Bourgine, Benjamin Vesin, Delphine Cussigh, et al. (+12)
16 [GO] 2023―Jan―19 Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy Isabel Hodl, Clarissa Sallegger, Patrick Forstner, Nazanin Sareban, Martina Moritz, Barbara Dreo, et al. (+14)
17 [GO] 2023―Jan―16 Salmonella-mediated oral delivery of multiple-target vaccine constructs with conserved and variable regions of SARS-CoV-2 protect against the Delta and Omicron variants in hamster Khristine Kaith S. Lloren, Vijayakumar Jawalagatti, Chamith Hewawaduge, Chandran Sivasankar, Ji-Young Park, John Hwa Lee
18 [GO] 2022―Dec―17 Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19 Mohadeseh Hasanpourghadi, Mikhail Novikov, Robert Ambrose, Arezki Chekaoui, Dakota Newman, Jianyi Ding, et al. (+6)
19 [GO] 2022―Dec―07 Association of complement pathways with COVID-19 severity and outcomes Kishor Devalaraja-Narashimha, Peter J. Ehmann, Cong Huang, Qin Ruan, Matthew F. Wipperman, Theodore Kaplan, et al. (+10)
20 [GO] 2022―Nov―23 Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals? Sharvan Sehrawat, Nikolaus Osterrieder, D.Scott Schmid, Barry T. Rouse
21 [GO] 2022―Nov―16 SARS-CoV-2 neutralizing antibody response in vaccinated and non-vaccinated hospital healthcare workers with or without history of infection Damien Jacot, Urs von Rotz, Céline Pellaton, Fanny Blondet, Oriane Aebischer, Matthieu Perreau, et al. (+4)
22 [GO] 2022―Oct―12 Mycobiome profiling of nasopharyngeal region of SARS-CoV-2 infected individuals Abhishek Gupta, Shivang Bhanushali, Rajesh Karyakarte, Suvarna Joshi, Rashmita Das, Yogesh Shouche, Avinash Sharma
23 [GO] 2022―Sep―09 Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines Yu-An Kung, Sheng-Yu Huang, Chung-Guei Huang, Kuan-Ting Liu, Peng-Nien Huang, Kar-Yee Yu, et al. (+10)
24 [GO] 2022―Aug―24 COVID-19 and Fungal Infections: A Double Debacle Sara Mina, Hajar Yaakoub, Cédric Annweiler, Vincent Dubée, Nicolas Papon
25 [GO] 2022―Apr―20 Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection Purwa Doke, Jayshree Sachin Gothankar, Prakash Prabhakarrao Doke, Milind Madhukar Kulkarni, Kiran Kishanrao Khalate, Shubham Shrivastava, et al. (+2)
26 [GO] 2022―Apr―04 Humoral Immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients Emanuela Anastasi, Marco Marziali, Adele Preziosi, Elena Berardelli, Anna Annunziata Losardo, Michela Ribersani, et al. (+4)
27 [GO] 2022―Feb―28 Miller-Fisher syndrome associated with SARS-CoV-2: a case report Dr L. Faulkner, Dr S. Scott, Dr NJ. Flint
28 [GO] 2022―Feb―02 Clinical and genomic data of sars-cov-2 detected in maternal-fetal interface during the first wave of infection in brazil Maria de Fátima Carvalho Ferreira, Janeth Aracely Ramirez Pavon, Amanda Colichio Bini Napoleão, Gláucia Maria Duarte Preza Figueiredo, Patricia Cristina Borges Florêncio, Rayssa Basílio dos Santos Arantes, et al. (+6)
29 [GO] 2022―Jan―31 Application experience of a rapid nucleic acid detection system for COVID-19 Qing Ye, Dezhao Lu, Ting Zhang, Jianhua Mao, Shiqiang Shang
30 [GO] 2021―Dec―03 Impact of non-pharmaceutical interventions during the COVID-19 pandemic on common childhood respiratory viruses - A epidemiological study based on hospital data Qing Ye, Huihui Liu
31 [GO] 2021―Nov―25 NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity Saiful Amin, Salma Aktar, Md. Mijanur Rahman, Mohammed Mehadi Hassan Chowdhury
32 [GO] 2021―Sep―15 Phytomelatonin: a potential phytotherapeutic intervention on COVID-19-exposed individuals Emmanuel Sunday Okeke, Martins Obinna Ogugofor, Ndidi Ethel Nkwoemeka, Ekene John Nweze, Charles Obinwanne Okoye
33 [GO] 2021―Aug―21 Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types Abhishek Gupta, Rajesh Karyakarte, Suvarna Joshi, Rashmita Das, Kunal Jani, Yogesh Shouche, Avinash Sharma
34 [GO] 2021―Aug―19 The COVID-19 epidemic and other notifiable infectious diseases in China Bing-ke Bai, Qi-yu Jiang, Jun Hou
35 [GO] 2021―Jun―18 Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo Naveen Yadav, Preeti Vishwakarma, Ritika Khatri, Gazala Siddqui, Amit Awasthi, Shubbir Ahmed, Sweety Samal
36 [GO] 2021―Jun―12 The role of sexual dimorphism in susceptibility to SARS-CoV-2 infection, disease severity, and mortality: facts, controversies and future perspectives Stavroula Pegiou, Elpiniki Rentzeperi, Theocharis Koufakis, Symeon Metallidis, Kalliopi Kotsa
37 [GO] 2021―Jun―11 Airborne infection with Covid-19? A historical look at a current controversy Igor J. Polianski
38 [GO] 2021―May―20 Development of leading first-generation vaccines against SARS-CoV-2 Pin-Yu Perera, Liyanage P. Perera
39 [GO] 2021―Apr―19 Management of COVID-19: Current Status and Future Prospects Md Alamgir Kabir, Rajib Ahmed, Rasheduzzaman Chowdhury, Sheikh Muhammad Asher Iqbal, Ramasamy Paulmurugan, Utkan Demirci, Waseem Asghar
40 [GO] 2021―Mar―27 Had COVID-19 spread in the community before the first confirmed case in Nagasaki, Japan? Norihito Kaku, Kenji Ota, Daisuke Sasaki, Norihiko Akamatsu, Naoki Uno, Kei Sakamoto, et al. (+5)
41 [GO] 2021―Mar―20 “Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering.” A. Farina, R. Labriola, C. Ialongo, M. Suppa, V. Viggiani, M. Lucarelli, et al. (+2)
42 [GO] 2021―Mar―18 Prolonged Viral Shedding and Antibody Persistence in Patients with COVID-19 Fatemeh Fotouhi, Mostafa Salehi-Vaziri, Behrokh Farahmand, Ehsan Mostafavi, Mohammad Hassan Pouriayevali, Tahmineh Jalali, et al. (+9)
43 [GO] 2021―Mar―18 COVID-19 Vaccine Decisions: Considering the Choices and Opportunities Peter J. Hotez, Tasmiah Nuzhath, Timothy Callaghan, Brian Colwell
44 [GO] 2021―Mar―06 Bacterial and fungal co-infections among COVID-19 patients in intensive care unit Siyuan Yang, Mingxi Hua, Xinzhe Liu, Chunjing Du, Lin Pu, Pan Xiang, et al. (+2)
45 [GO] 2021―Mar―02 Recurrence of COVID-19 after recovery ? A case series in health care workers, France Souheil Zayet, Pierre-Yves Royer, Lynda Toko, Alix Pierron, Vincent Gendrin, Timothée Klopfenstein
46 [GO] 2021―Feb―03 Personalized Stewardship and Interdisciplinarity: Key Elements of COVID-19 Tommaso Lupia, Silvia Corcione, Francesco G. De Rosa
47 [GO] 2021―Jan―20 Could targeting immunometabolism be a way to control the burden of COVID-19 infection? Engin Berber, Deepak Sumbria, Barry T. Rouse
48 [GO] 2021―Jan―14 COVID-19: Disease, or no disease? - that is the question. It’s the dose stupid! Sharvan Sehrawat, Barry T. Rouse
49 [GO] 2020―Nov―07 Digging the Rabbit Hole, COVID-19 Edition: Anti-Vaccine Themes and the Discourse Around COVID-19 Tara C. Smith, Dorit Rubinstein Reiss
50 [GO] 2020―Oct―14 SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector Lena Faust, Alexandra J. Zimmer, Mikashmi Kohli, Senjuti Saha, Jody Boffa, Marlon L. Bayot, et al. (+21)
51 [GO] 2020―Oct―10 COVID-19: comparative clinical features and outcome in 114 patients with or without pneumonia (Nord Franche-Comte Hospital, France) N’dri Juliette Kadiane-Oussou, Timothee Klopfenstein, Pierre-Yves Royer, Lynda Toko, Vincent Gendrin, Souheil Zayet
52 [GO] 2020―Oct―10 Non-synonymous Mutations of SARS-CoV-2 Leads Epitope Loss and Segregates its Variants Aayatti Mallick Gupta, Jaydeb Chakrabarti, Sukhendu Mandal
53 [GO] 2020―Sep―22 Low-impact social distancing interventions to mitigate local epidemics of SARS-CoV-2 Michael L. Jackson
54 [GO] 2020―Sep―19 Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system Nina Marí G.P. de Queiroz, Fabio V. Marinho, Marcelo A. Chagas, Luciana C.C. Leite, E. Jane Homan, Mariana T.Q. de Magalhães, Sergio C. Oliveira
55 [GO] 2020―Sep―07 Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses Damien Jacot, Gilbert Greub, Katia Jaton, Onya Opota
56 [GO] 2020―Sep―04 Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis Flavio De Maio, Ettore Lo Cascio, Gabriele Babini, Michela Sali, Stefano Della Longa, Bruno Tilocca, et al. (+5)
57 [GO] 2020―Jul―09 Opinion: Does the hygiene hypothesis apply to COVID-19 susceptibility? Sharvan Sehrawat, Barry T. Rouse
58 [GO] 2020―Jun―26 Coronavirus Vaccine-Associated Lung Immunopathology-What Is The Significance? Maria Elena Bottazzi, Ulrich Strych, Peter J. Hotez, David B. Corry
59 [GO] 2020―Jun―24 Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19 Jeremia M. Coish, Adam J. MacNeil
60 [GO] 2020―Jun―20 Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19) Anne Lohse, Timothée Klopfenstein, Jean-Charles Balblanc, Pierre-Yves Royer, Marie Bossert, Vincent Gendrin, et al. (+8)
61 [GO] 2020―Jun―16 Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster Souheil Zayet, N’dri Juliette Kadiane-Oussou, Quentin Lepiller, Hajer Zahra, Pierre-Yves Royer, Lynda Toko, et al. (+2)
62 [GO] 2020―May―21 Immunoinformatic analysis of the SARS-CoV-2 Envelope protein as a strategy to assess cross-protection against COVID-19 Bruno Tilocca, Alessio Soggiu, Maurizio Sanguinetti, Gabriele Babini, Flavio De Maio, Domenico Britti, et al. (+4)
63 [GO] 2020―May―18 Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study Zhihua Lv, Shaohua Cheng, Juan Le, Jingtao Huang, Lina Feng, Binghong Zhang, Yan Li
64 [GO] 2020―May―18 A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients Lei Liu, Wanbing Liu, Yaqiong Zheng, Xiaojing Jiang, Guomei Kou, Jinya Ding, et al. (+19)
65 [GO] 2020―May―16 Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency Shawn J. Green
66 [GO] 2020―May―13 Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season Chao Jiang, Xingang Yao, Yulin Zhao, Jianmin Wu, Pan Huang, Chunhua Pan, et al. (+2)
67 [GO] 2020―May―11 From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development Cuiqing Ma, Shan Su, Jiachao Wang, Lin Wei, Lanying Du, Shibo Jiang
68 [GO] 2020―May―07 Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China Yan Ma, Qing-nan Xu, Feng-li Wang, Xiao-man Ma, Xiao-yan Wang, Xiao-guo Zhang, Zhong-fa Zhang
69 [GO] 2020―May―06 The Forrest Gump approach to preventing severe COVID-19 - reverse the predisposing pro-inflammatory state with exercise Chris Kenyon
70 [GO] 2020―May―06 Current development of COVID-19 diagnostics, vaccines and therapeutics Naru Zhang, Chaoqun Li, Yue Hu, Kangchen Li, Jintian Liang, Lili Wang, et al. (+2)
71 [GO] 2020―May―06 Could nasal nitric oxide help to mitigate the severity of COVID-19? Jan Martel, Yun-Fei Ko, John D. Young, David M. Ojcius
72 [GO] 2020―Apr―30 Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes Mario Adán Moreno-Eutimio, Constantino López-Macías, Rodolfo Pastelin-Palacios
73 [GO] 2020―Apr―22 The fate of house cats during the COVID-19 pandemic Tianyue Gao, Xingchen Pan, Chungen Pan
74 [GO] 2020―Apr―17 Chloroquine Paradox May Cause More Damage Than Help Fight COVID-19 Anuj Sharma
75 [GO] 2020―Apr―17 The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement Peter J. Hotez, Maria Elena Bottazzi, David B. Corry
76 [GO] 2020―Apr―14 Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses Bruno Tilocca, Alessio Soggiu, Maurizio Sanguinetti, Vincenzo Musella, Domenico Britti, Luigi Bonizzi, et al. (+2)
77 [GO] 2020―Apr―08 Emergency response to the outbreak of COVID-19: the Korean case Kyoo-Man Ha
78 [GO] 2020―Apr―05 It is too soon to attribute ADE to COVID-19 Anuj Sharma
79 [GO] 2020―Mar―19 Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 Ye Qiu, Yuan-Bo Zhao, Qiong Wang, Jin-Yan Li, Zhi-Jian Zhou, Ce-Heng Liao, Xing-Yi Ge
80 [GO] 2020―Mar―17 Molecular basis of COVID-19 relationships in different species: a one health perspective Bruno Tilocca, Alessio Soggiu, Vincenzo Musella, Domenico Britti, Maurizio Sanguinetti, Andrea Urbani, Paola Roncada
81 [GO] 2020―Feb―22 Is COVID-19 Receiving ADE From Other Coronaviruses? Jason A. Tetro
82 [GO] 2020―Feb―21 Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases Xingchen Pan, David M. Ojcius, Tianyue Gao, Zhongsheng Li, Chunhua Pan, Chungen Pan
83 [GO] 2020―Feb―21 The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future Jin-Yan Li, Zhi You, Qiong Wang, Zhi-Jian Zhou, Ye Qiu, Rui Luo, Xing-Yi Ge
84 [GO] 2020―Feb―20 Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses Jieliang Chen
85 [GO] 2020―Feb―01 Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China Fei Yu, Lanying Du, David M. Ojcius, Chungen Pan, Shibo Jiang
 [1] 

85 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec